Massimo is a molecular biologist graduated (BSc) with honors in Biological Sciences from the University of Naples "Federico II" in 1999. He also holds a PhD in Biophysics from the Catholic University of Rome in 2010. He obtained the researcher position at the “Health and Environment" Division of Health Protection Technologies, ENEA Casaccia Research Center of Rome in 2021.

Massimo started his working activity (from 2000 to 2004) in the Department of Molecular Cardiology, IRCCS Fondazione "Maugeri" of Pavia, developing a conditional knock-in of mouse RyR2 gene (grant Telethon, GP0227Y01) and characterizing mutations on Kir 2.3, Actin B, casq2, Cav1.2 genes in patients with long QT syndrome. He was also a visiting researcher at the Departments of Physiology and cell Biology and Biochemistry, Texas Tech University Health Sciences center, Lubbock, Texas, USA, to develop adenoviral and lentiviral vectors for gene therapy in myocytes.

From 2005 to 2011 Massimo worked at the Department of Neuroscience, IRCCS Fondazione “Gemelli”, Catholic University of Rome, with experimental activity based on the correlation genotype-fenotype in muscle cells and tissue from patients affected by myotonic dystrophy type 1 (DM1) and type 2 (DM2) using several molecular biology techniques. In 2011 he moved to Fondazione Don Carlo Gnocchi of Rome to create a research laboratory aimed at studying molecular bases of several neurological disorders and rare diseases with specific technologies applied to genetic and epigenetics studies.

In 2021 Massimo began his research activity at ENEA where he deals with characterizing the cellular response to non-ionizing radiations, natural and food-derived bio-molecules using molecular biology, genetics and epigenetics approaches.

Email: massimo.santoro@enea.it